The wolframin His611Arg polymorphism influences medication overuse headache

被引:30
作者
Di Lorenzo, C. [1 ]
Sances, G.
Di Lorenzo, G.
Rengo, C.
Ghiotto, N.
Guaschino, E.
Perrotta, A.
Santorelli, F. M.
Grieco, G. S.
Troisi, A.
Siracusano, A.
Pierelli, F.
Nappi, G.
Casali, C.
机构
[1] Univ La Sapienza, UCADH, Dept Neurol & ORL, Latina, Italy
[2] IRCCS, C Mondino Inst Neurol Fdn, UCADH, Headache Unit, Pavia, Italy
[3] Univ Roma Tor Vergata, Dept Neurosci, Psychiat Clin, Rome, Italy
[4] IRCCS San Raffaele, C Mondino Inst Neurol Fdn, Mol Genet Lab, Rome, Italy
[5] IRCCS Bambino Gesu, Rome, Italy
关键词
wolframin; genetic polymorphisms; secondary headache disorder; drug overuse; addictive behaviour;
D O I
10.1016/j.neulet.2007.07.037
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Homozygosis for wolframin (WFS1) mutations determines Wolfram syndrome (WS), and common polymorphisms of WFS1 are associated with psychiatric illnesses and dependence behaviour. To test the influence of WFS1 polymorphisms on medication overuse headache (MOH), a chronic headache condition related to symptomatic drugs overuse, we analyzed 82 MOH patients for the WFS1 His61 lArg polymorphism, and performed a comparison between clinical features of Arg/Arg (R/R) and non-R/R individuals. Individuals harbouring the R/R genotype showed significantly higher monthly drug consumption (t= -3.504; p =0.00075) and more severe depressive symptoms on the BDI questionnaire -3.048; p = 0.003) than non-R/R. WFS1 polymorphism emerged as the only significant predictor of drug consumption, at the multivariate, regression analysis (F = 12.277; d.f. = 1,80; p = 0.00075, adjusted R-2 = 0.122). These results implicate WFS1 in the clinical picture of MOH, may be through an influence on need for drugs as in other conditions of abuse behaviour. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 36 条
  • [11] Role of intracellular calcium in acute thermal pain perception
    Galeotti, N
    Bartolini, A
    Ghelardini, C
    [J]. NEUROPHARMACOLOGY, 2004, 47 (06) : 935 - 944
  • [12] Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1
    Hardy, C
    Khanim, F
    Torres, R
    Scott-Brown, M
    Seller, A
    Poulton, J
    Collier, D
    Kirk, J
    Polymeropoulos, M
    Latif, F
    Barrett, T
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (05) : 1279 - 1290
  • [13] A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)
    Inoue, H
    Tanizawa, Y
    Wasson, J
    Behn, P
    Kalidas, K
    Bernal-Mizrachi, E
    Mueckler, M
    Marshall, H
    Donis-Keller, H
    Crock, P
    Rogers, D
    Mikuni, M
    Kumashiro, H
    Higashi, K
    Sobue, G
    Oka, Y
    Permutt, MA
    [J]. NATURE GENETICS, 1998, 20 (02) : 143 - 148
  • [14] Cat odour exposure increases the expression of wolframin gene in the amygdaloid area of rat
    Koks, S
    Planken, A
    Luuk, H
    Vasar, E
    [J]. NEUROSCIENCE LETTERS, 2002, 322 (02) : 116 - 120
  • [15] Neuroadaptive mechanisms of addiction: studies on the extended amygdala
    Koob, GF
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 (06) : 442 - 452
  • [16] Dimensional models for research and diagnosis: A current dilemma
    Kupfer, DJ
    [J]. JOURNAL OF ABNORMAL PSYCHOLOGY, 2005, 114 (04) : 557 - 559
  • [17] A RAPID NONENZYMATIC METHOD FOR THE PREPARATION OF HMW DNA FROM BLOOD FOR RFLP STUDIES
    LAHIRI, DK
    NURNBERGER, JI
    [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (19) : 5444 - 5444
  • [18] Medication overuse headache: Biobehavioral issues and solutions
    Lake, Alvin E., III
    [J]. HEADACHE, 2006, 46 : S88 - S97
  • [19] THE ROLE OF CALCIUM CHANNELS IN DRUG-DEPENDENCE
    LITTLE, HJ
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1995, 38 (02) : 173 - 194
  • [20] Opioid-induced abnormal pain sensitivity
    Mao J.
    [J]. Current Pain and Headache Reports, 2006, 10 (1) : 67 - 70